Extracted from this filing and checked against the source text.
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
Mountain Crest Acquisition Corp. V terminated Business Combination Agreement with AUM Biosciences Pte. Ltd. valued at Termination notice received from AUM; Business Combination Agreement terminated as of June 8, 2023. (effective 2023-06-08).
- Action
- termination
- Agreement
- merger
- Counterparty
- AUM Biosciences Pte. Ltd.
- Value
- Termination notice received from AUM; Business Combination Agreement terminated as of June 8, 2023.
- Effective
- 2023-06-08
Exact text from the filing
Item 1.02. Termination of a Material Definitive Agreement As previously disclosed, on October 19, 2022, Mountain Crest Acquisition Corp. V (“Mountain Crest” or “SPAC”) and AUM Biosciences Pte. Ltd., a private company limited by shares incorporated in Singapore, with company registration number 201810204D (“AUM” or the “Company”) entered into that certain Business Combination Agreement (as amended, supplemented or otherwise modified from time to time, the “Business Combination Agreement”), which was subsequently amended on February 10, 2023, March 30, 2023 and April 19, 2023. On January 27, 2023, AUM Biosciences Limited, a Cayman Islands exempted company (“Holdco”), AUM Biosciences Subsidiary Pte. Ltd., a private company limited by shares incorporated in Singapore, with company registration number 202238778Z and a direct, wholly-owned subsidiary of Holdco, and AUM Biosciences Delaware Merger Sub, Inc., a Delaware corporation and a direct, wholly-owned subsidiary of Holdco, executed a jo
View on SEC.gov